In all patients for whom dosing information was available (stickstoff=191) from the open-label and double-blind studies involving oxycodone HCl, the following adverse events were recorded in oxycodone HCl treated patients with an incidence ? 3%.The concomitant use of oxycodone HCl and CYP3A4 inhibitors can increase the plasma concentration of oxyco